Diagnosis and Surgical Management of Insulinomas-A 23-Year Single-Center Experience
- PMID: 37629713
- PMCID: PMC10456644
- DOI: 10.3390/medicina59081423
Diagnosis and Surgical Management of Insulinomas-A 23-Year Single-Center Experience
Abstract
Background and Objectives: Insulinoma is a rare tumor of the Langerhans islets of the pancreas. It produces insulin and causes severe hypoglycemia with neuroglycopenic symptoms. The incidence is low, at about 1-2 per 1 million inhabitants per year. The diagnosis is based on the presence of Whipple's triad and the result of a fasting test. Surgery is the treatment of choice. Objectives: A retrospective observational study of patients operated on for insulinoma in our hospital focused on the diagnosis, the type of surgery, and complications. Materials and Methods: We retrospectively reviewed patients operated on due to insulinoma. There were 116 surgeries between 2000 and 2022. There were 79 females and 37 males in this group. A fasting test and a CT examination were performed on all the patients. Results: The average duration of the fasting test was 18 h. Insulinoma was found in the body and tail of the pancreas in more than half of the patients. Enucleation was the most frequent type of surgery. Complications that were Clavien Dindo grade III or more occurred in 18% of the patients. The most frequent complications were abscesses and pancreatic fistula. Five patients had malignant insulinoma. Conclusions: Surgery is the treatment of choice in the case of insulinomas. The enucleation of the tumor is a sufficient treatment for benign insulinomas, which are not in contact with the main pancreatic duct. Due to the low incidence of the condition, the centralization of patients is recommended.
Keywords: Whipple’s triad; hypoglycemia; insulinoma; pancreas.
Conflict of interest statement
The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript; or in the decision to publish the results.
Figures
Similar articles
-
The surgical management of insulinoma.Bol Asoc Med P R. 2004 Jan-Feb;96(1):33-8. Bol Asoc Med P R. 2004. PMID: 15575328 Review.
-
Pancreatic insulinomas: experience in 220 patients.Zhonghua Wai Ke Za Zhi. 2000 Jan;38(1):10-3. Zhonghua Wai Ke Za Zhi. 2000. PMID: 11831975
-
Diagnosis and surgical management of insulinomas in 33 consecutive patients at a single institution.Langenbecks Arch Surg. 2016 Nov;401(7):1019-1025. doi: 10.1007/s00423-016-1496-y. Epub 2016 Aug 19. Langenbecks Arch Surg. 2016. PMID: 27539217
-
Pancreatic insulinomas: diagnosis and surgical treatment of 74 patients.Hepatobiliary Pancreat Dis Int. 2002 Aug;1(3):458-61. Hepatobiliary Pancreat Dis Int. 2002. PMID: 14607727
-
Case presentation of 8-year follow up of recurrent malignant duodenal Insulinoma and lymph node metastases and literature review of malignant Insulinoma management.BMC Endocr Disord. 2022 Dec 9;22(1):310. doi: 10.1186/s12902-022-01219-9. BMC Endocr Disord. 2022. PMID: 36494838 Free PMC article. Review.
Cited by
-
Pancreatic Neuroendocrine Tumors-Diagnostic Pitfalls of Non-Diabetic Severe Hypoglycemia: Literature Review and Case Report.Diagnostics (Basel). 2025 Jan 31;15(3):337. doi: 10.3390/diagnostics15030337. Diagnostics (Basel). 2025. PMID: 39941267 Free PMC article.
-
Endoscopic ultrasonography-based intratumoral and peritumoral machine learning radiomics analyses for distinguishing insulinomas from non-functional pancreatic neuroendocrine tumors.Front Endocrinol (Lausanne). 2024 Jun 17;15:1383814. doi: 10.3389/fendo.2024.1383814. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38952387 Free PMC article.
-
Clinical characteristics and treatment outcomes of patients with insulinoma-a single center's experience of 76 cases over a 10-year period.Heliyon. 2025 Jan 10;11(2):e41799. doi: 10.1016/j.heliyon.2025.e41799. eCollection 2025 Jan 30. Heliyon. 2025. PMID: 39897806 Free PMC article.
-
Enucleation for insulinoma: consolidating evidence through systematic review and meta-analysis.Surg Endosc. 2025 Sep 2. doi: 10.1007/s00464-025-12099-0. Online ahead of print. Surg Endosc. 2025. PMID: 40897878 Review.
References
-
- Peltola E., Hannula P., Huhtala H., Metso S., Kiviniemi U., Vornanen M., Sand J., Laukkarinen J., Tiikkainen M., Schalin-Jäntti C., et al. Characteristics and Outcomes of 79 Patients with an Insulinoma: A Nationwide Retrospective Study in Finland. Int. J. Endocrinol. 2018;2018:2059481. doi: 10.1155/2018/2059481. - DOI - PMC - PubMed
-
- Durczyński A., Hogendorf P., Szymański D., Izdebski W., Kaczka A., Durko Ł., Strzelczyk J. Insulinoma—rare, but important clinical problem. Analysis of a Series of 530 Patients Who Underwent Surgical Treatment for the Pancreatic Tumor. Pol. J. Surg. 2015;86:505–510. doi: 10.2478/pjs-2014-0090. - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical